Regulatory T cells (Treg), a component of adaptive immunity, are well known for their immunosuppressive roles and their ability to maintain the balance between the immunological and pathological reactions. Treg have been shown to provide protective responses and their depletion has resulted severe pathology in some pathogen infections. The work presented here has unravelled the potential of regulatory cells in the immune system including different repertoir of Treg cell subsets, markers to distinguish them, Treg suppression mechanisms in the pathogenesis of various infections and summarize different mouse models depleting Tregs. These findings would help set up future avenues of research to elucidate a key mechanism of action of these cells and provide new therapeutic insights for pathogenesis and also for broader antibacterial/antiviral/antiproliferative immunity.
tionally distinct group that has been recognised as vital for keeping the immune system in check, aiding it to escape from self-targeted pathology and unhindered selection of both T and B cell populations [1] [2] . In order to maintain a delicate balance, immune system is required to respond to pathogens, nevertheless is must tolerate beneficial microbes. It is widely acknowledged that Treg play a major role in minimizing deleterious immune mediated pathology caused by harmful microbes and self-antigens and thus making a significant impact to this balance.
Treg
Treg are currently thoroughly investigated for their key role in the maintenance of balance between the immunological and pathological reactions over the body [3] [4] . They are crucial for the retainment of self-tolerance and the control of immune responses against pathogenic organisms, tumour antigens as well as allergens [5] [6] [7] [8] [9] . Treg are developmentally and functionally different from conventional T cells. Treg constitute 5% to 10% of CD4 + T cells. In the steady state, they are generated in the thymus and can be induced from naïve CD4 + T cells in the periphery.
Treg are initially characterized as expressing a CD4 + CD25 high phenotype [10] [11]. However, an increasing number of markers have been identified that express constitutively on Treg. These include: cytotoxic T lymphocyte antigen 4
(CTLA-4), glucocorticoid-induced tumour necrosis factor receptor family related protein (GITR); TNFRSF18 (GITR), CD39, HLA-DR, CD45RA, OX40, CD127 lo , and CD73 [12]- [17] . In fact, none of these surface markers are expressed exclusively on Treg. Moreover, as CD25 is expressed on other activated T cells and there are some Treg in the peripheral tissues which do not express CD25 limiting the use of this marker for Treg [18] [19] [20] [21] . To date the most specific marker identified for the classification of Treg is expression of the transcription factor recognized as forkhead box P3 (Foxp3) [22] , which has been exhibited to be expressed specifically in CD4 + T cells. The Foxp3 gene encodes Scurffin, which is identified as a member of forkhead-winged-helix family of transcriptional regulators and is vastly conserved in humans [23] . In mice neither activated CD4 + T cells nor differentiated Th1/Th2 cells express Foxp3 [24] [25]. Foxp3 is found to be expressed almost exclusively by CD4 + CD25 + T cells in both thymus and periphery [26] . Mutation of Foxp3 causes an aggressive X-linked autoimmune disease in scurfy mice [23] and the human equivalent, immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) [27] 
Functions of Treg
Preliminary studies with Treg were based on their role in dominant tolerance and development of autoimmune disease. However, a handful of studies indicate that Treg play roles in the development of allergic diseases (reviewed in [34] ), in the suppression of anti-tumour immunity [35] , during pathogen infection (reviewed in [4] ) and in controlling responses to commensal microbes in inflammatory diseases [36] . Treg are well known for their immunosuppressive role of varying immune cells including non-Treg CD4 + T cells [37] , CD8 + T cells [38] , dendritic cells (DC) [39] , B cells [40] , Th17 cells [41] , natural killer (NK) cells [42] , macrophages [43] and mast cells [44] which are activated in response to pathogen ( Figure 1 ). 
Different Subsets of Treg

Thymus Derived Treg (tTreg)
Treg that develop within the thymus were often referred to as natural Treg cells as opposed to peripherally derived Treg [46] . tTreg arise during the normal process of T cell development in the thymus and are imprinted with regulatory function before being released into the periphery. They help prevent autoimmunity and are resistant to thymic deletion and are non-redundantly required for the establishment of self-tolerance [49] [50] . tTreg are known to suppress effector T cell proliferation in vitro through cytokine independent fashion that is mostly cell contact dependent [51] . The proportion of tTreg appears to be small when any part of this population reacts with antigens [52] . In thymus, tTreg can develop from progenitors to tTreg through tTreg precursor cells [53] IL21, an autocrine growth factor drives the proliferation of Tr1 cells [107] ICOS stimulates the IL27-induced differentiation of Tr1 [105] AhR induced by IL27 shown to be involved in the differentiation of Tr1 [108] [109]
Th3
Th3 mediate their suppressive activity by the production of TGF-β. [110] Th3 exhibit a mutual relationship with Th17 cells and exert regulatory potentials [111] [112].
Tr35
Tr35 are involved in IL-35 production [113] T. Medullary thymic epithelial cells (mTECs) are responsible for inducing selection of thymic tTreg, also bone marrow derived APCs can facilitate tTreg differentiation [2] . Either mTECs or bone derived APCs alone may be sufficient for the generation of tTreg numbers and both of these subsets can present self-antigens in order to induce development of tTReg [69] .
Peripherally Derived Treg
Cell pTreg develop extra-thymically when they are exposed to certain regulatory cytokines which are released during inflammatory conditions, upon encountering cognate antigens and costimulation [70] [71]. The antigen-specific Treg repertoire is more abundant than tTreg population and in contrast to tTreg, they migrate towards the sites of inflammation [72] . pTreg play an indispensible role in establishing peripheral tolerance to commensal microbes in gut and non-pathogenic environmental antigens derived from food and they express predominantly in mucosa associated lymphoid tissues (MALT) including peyer's patches and lamina propria of small and large intestines [73] [74]. Moreover, pTreg which present only in the placental mammals are involved in the establishment of maternal-foetal tolerance [75] . Their suppressive actions are mostly cell contact independent and depend on the availability of immunosuppressive repressor that inhibits Treg differentiation [85] . TGF-β also antagonizes DNA methyltransferase 1 (Dnmt1), which inhibits the expression of Foxp3 [86] .
CNS-1, a non-coding region of Foxp3 locus are a crucial regulatory element in the generation of pTreg [87] . CNS1, which possesses a TGFβ-NFAT response element are involved in pTreg differentiation in GALT [88] . 
Markers to Distinguish tTreg from pTreg
The tTreg vary in functionality from pTreg, however, the major problem in exploring the relative function of these two subsets is the lack of markers to distinguish the two populations.
Helios, a T cell restricted member of Ikaros family transcription factor has been demonstrated to be useful for distinguishing these two Treg populations
[124] [125] . Helios is preferentially expressed by tTreg, whereas Treg generated in vitro and in vivo are negative for Helios expression [124] . However, others have described that pTreg can express Helios as when T cells were stimulated with irradiated splenocytes, more than half of the pTreg expressed Helios [126] .
In addition, Helios is also expressed on Th2 and T follicular helper cells and is related to the differentiation of these cells [127] . It is reported that activated Foxp3 T cells also express helios and in fact a marker for Treg activation [128] .
Also expression of Helios has been shown to be associated with T cell tolerance in both thymus and periphery [129] . Thus Helios does not appear to be a marker to distinguish pTreg from tTreg.
Neuropilin-1 (Nrp1) expression, a neuronal receptor of the class 3 semaphorin subfamily and a co-receptor for vascular endothelial growth factor A, offers another biological marker to distinguish tTreg from pTreg [130] [131].
In contrast to low levels of Nrp1 expressed on pTreg, majority of tTreg express Nrp1 [130] . However, others have demonstrated that Treg generated extrathymically in the central nervous system during a spontaneous model of EAE were Nrp+ [125] . In addition, Nrp1 is not a marker for human Treg [132] .
Thus Nrp1 appeared to be an imperfect marker to distinguish pTreg from tTreg. 
Mechanism of Suppression of Treg
To date a number of mechanisms have been associated with the suppressive ac- [141] and skin hypersensitivity [142] .
TGF-β, is a well-recognized inhibitory cytokine, however, the function of TGF-β in Treg mediated suppression has some controversies ( Figure 2 ). Mice with a T-cell specific deletion of tgfb1 gene developed lethal immunopathology and could not inhibit inflammatory bowel disease in a transfer model [143] .
TGF-β was found to be the major mechanism of suppression of prostate tumour infiltrating CD8 cells [144] . Ebi3 and IL-12α-deficient mice have a reduced suppressive capability in vitro and fail to cure inflammatory bowel disease in vivo [148] .
There is evidence that Treg can indirectly suppress other cells through modu- [155] [156] . Moreover, anti-CTLA4 inhibits the ability of Treg cells to suppress colitis [154] .
Treg cells can induce the expression of indoleamine 2, 3-dioxygenase (IDO) in
DCs in a CTLA4-dependent manner [157] . IDO is a potent immunosuppressive enzyme which induces catabolism of tryptophan in to pro-apoptotic metabolites, resulting in the suppression of effector cells [158] . Ligation of CTLA-4 to CD80 and CD86 induce DCs by activating transcription factor Foxo3, which downregulate production of IL-6 and TNFα by DCs [159] .
Other molecules expressed by Treg that can affect the function of DCs are:
Lymphocyte activation gene-3 (LAG-3) [160] [161], immunoreceptor tyrosine-based activation motif (ITAM) [162] and Fibrinogen-like protein 2 (FGL2) [163] . Treg cells from LAG-3 deficient mice had a decreased suppressive activity and anti-LAG-3 blocked suppressive activity of Treg cells both in vitro and in vivo [160] [164] . Advances in Bioscience and Biotechnology
Treg cells can suppress DC maturation by inhibiting down-regulation of MARCH1 and upregulation of CD83 [165] . MARCH1, a membrane bound E3 ubiquitin ligase, was found to degrade CD86 and MHC-II on DC by directing them to the late endosomal or lysosomal compartment [166] . CD83 is accompanied by DC maturation and it inhibits the action of MARCH1 [167] . Treg use IL-10 to influence MARCH1-CD83 pathway.
There is growing evidence that Programmed death 1 (PD-1) pathway plays a role in Treg mediated suppression [169] [170] . PD-1 is expressed predominantly on exhausted CD8 cells and PD-L1, the ligand for PD-1is expressed on Treg and tumour cells [171] . halts the effector T cell activity by the expanding Treg [181] .
Treg has been found to exert metabolic disruption in target cells by their expression of ectoenzymes CD39 and CD73. Treg from CD39 deficient mice have reduced suppressive functions both in vitro and in vivo [182] . CD39 and CD73
convert proinflammatory nucleotides to anti-inflammatory adenosine and these ectoenzymes catalyse the generation of perinuclear adenosine from extracellular ATP or ADP [183] . Adenosine generated in this process then suppresses effector T cells via binding to adenosine A2A receptor. 
Depletion of Treg Using Mouse Model
Concluding Remarks
There are complex dynamic suppression processes controlling other cells by 
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